The natural history of HIV disease in haemophilia

Blood Reviews

Volumn 12, Issue 3, 1998, Pages 135-144

  Lee, C A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; CHILD; DRUG CONTAMINATION; HEMOPHILIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 0031684225     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(98)90011-X     Document Type: Article

References (61)

1. Anonymous. Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30(21): 250-252.
2. Anonymous. Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR Morb Mortal Wkly Rep 1982; 31(27): 365-367.
3. Shilts R. And the band played on: politics, people, and the AIDS epidemic. Harmondsworth: Penguin Books, 1988.
4. Barre-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220(4599): 868-871.
5. Lee CA, Webster A, Griffiths PD, Kernoff PB. Symptomless HIV infection after more than ten years [letter: comment]. Lancet 1990; 335(8686): 425-426.
6. Lee CA, Phillips A, Elford J et al. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol 1989; 73(2): 228-234.
7. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987; 107(1): 1-6.
8. Chorba TL, Holman RC, Strine TW, Clarke MJ, Evatt BL. Changes in longevity and causes of death among persons with hemophilia A. Am J Hematol 1994; 45(2): 112-121.
9. Darby SC, Ewart DW, Giangrande PL, Dolin PJ, Spooner RJ, Rizza CR. Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation [see comments]. Nature 1995; 377(6544): 79-82.
10. Lee CA, Sabin CA, Phillips AN, Elford J, Pasi J Morbidity and mortality from transfusion-transmitted disease in haemophilia [letter; comment]. Lancet 1995; 345(8960): 1309.
11. Phillips AN, Sabin CA, Elford J, Bofill M, Janossy G, Lee CA. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ 1994; 309(6950): 309-313.
12. Phillips AN, Lee CA, Elford J et al. p24 antigenaemia CD4 lymphocyte counts and the development of AIDS. AIDS 1991; 5(10): 1217-1222.
13. Darby SC, Rizza CR, Doll R, Spooner RJ, Stratton IM, Thakrar B. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. BMJ 1989; 298(6680): 1064-1068.
14. Goedert JJ, Kessler CM, Aledort LM et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia [see comments]. N Engl J Med 1989; 321(17): 1141-1148.
15. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation [see comments]. Lancet 1996; 347(9015): 1573-1579.
16. Phillips AN, Lee CA, Elford J et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4 + T-cell counts. J Acquir Immune Defic Syndr 1991; 4(10): 970-975.
17. Allain JP, Laurian Y, Paul DA, Senn D. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet 1986; 2(8518): 1233-1236.
18. Cheingsong-Popov R, Panagiotidi C, Bowcock S, Aronstam A, Wadsworth J, Weber J. Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection. BMJ 1991; 302(6767): 23-26.
19. Phillips AN, Lee CA, Elford J et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337(8738): 389-392.
20. O'Brien TR, Blattner WA, Waters D et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study [see comments]. JAMA 1996; 276(2): 105-110.
21. Steel CM, Ludlam CA, Beatson D et al. HLA haplotype A 1 B8 DR3 as a risk factor for HIV-related disease. [Review] [26 refs]. Lancet 1988; 1(8596): 1185-1188.
22. Sahmoud T, Laurian Y, Gazengel C, Sultan Y, Gautreau C, Costagliola D. Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS 1993; 7(4): 497-500.
23. Aronstam A, Congard B, Evans DI et al. HIV infection in haemophilia - a European cohort. Arch Dis Child 1993; 68(4): 521-524.
24. Phillips AN, Sabin CA, Elford J, Bofill M, Lee CA, Janossy G. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 1993; 7(7): 975-980.
25. Simmonds P, Beatson D, Cuthbert RJ et al. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort [see comments]. Lancet 1991; 338(8776): 1159-1163.
26. Phillips AN, Sabin CA, Elford J et al. Serum beta 2-microglobulin at HIV-1 seroconversion as a predictor of severe immunodeficiency during 10 years of follow-up. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(3): 262-266.
27. Dean M, Carrington M, Winkler C et al. Genetic restriction of HIV-I infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study. San Francisco City Cohort, ALIVE Study [see comments]. Science 1996; 273(5283): 1856-1862.
28. Pasi KJ, Ononye C, Jenkins PV, Sabin CA, Lee CA. Analysis of CKR5 mutants in HIV infected haemophilic patients and HIV exposed but uninfected haemophilic patients. Blood 1996; 88(10 suppl 1): 654a.
29. O'Brien TR, Winkler C, Dean M et al. HIV-1 infection in a man homozygous for CCR5 delta 32 [letter]. Lancet 1997; 349(9060): 1219.
30. Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiol Infect 1995; 114(2): 361-372.
31. Youle MS, Gazzard BG, Johnson MA et al. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group [published erratum appears in AIDS 1994 Jun; 8(6): following 859]. 1994; 8(5): 641-649.
32. Rabkin CS, Hatzakis A, Griffiths PD et al. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group. J Infect Dis 1993; 168(5): 1260-1263.
33. Ratnoff OD, Menitove JE, Aster RH, Lederman MM. Coincident classic hemophilia and 'idiopathic' thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med 1983; 308(8): 439-442.
34. Ragni MV, Bontempo FA, Myers DJ, Kiss JE, Oral A. Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs. Blood 1990; 75(6): 1267-1272.
35. Karpatkin S. Immunologic thrombocytopenic purpura in HIV-seropositive homosexuals, narcotic addicts and hemophiliacs. [Review] [31 refs]. Semin Hematol 1988; 25(3): 219-229.
36. Stricker RB, Abrams DI, Corash L, Shuman MA. Target platelet antigen in homosexual men with immune thrombocytopenia [retracted by Shuman MA, Corash L. Hittelman KJ. In: N Engl J Med 1991; 325(21): 1487] [see comments]. N Engl J Med 1985; 313(22): 1375-1380.
37. Stricker RB, Abrams DI, Corash L, Shuman MA. Target platelet antigen in homosexual men with immune thrombocytopenia [retracted by Shuman MA, Corash L. Hittelman KJ. In: N Engl J Med 1991; 325(21): 1487] [see comments]. N Engl J Med 1985; 313(22): 1375-1380.
38. Ehmann WC, Rabkin CS, Eyster ME, Goedert JJ. Thrombocytopenia in HIV-infected and uninfected hemophiliacs. Multicenter Hemophilia Cohort study. Am J Hematol 1997; 54(4): 296-300.
39. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993; 6(6): 602-610.
40. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994; 87(3): 555-561.
41. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84(4): 1020-1023.
42. Telfer PT, Brown D, Devereux H, Lee CA, DuSheiko GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br J Haematol 1994; 88(2): 397-399.
43. Eyster ME, Hatzakis A. HCV genotypes in multitransfused hemophiliacs. Gastroenterology 1996; 110: A1187.
44. Sabin CA, Telfer P, Philips AN, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997; 175(1): 164-168.
45. Goldman E, Lee C, Miller R, Kernoff P, Morris-Smith J, Taylor B. Children of HIV positive haemophilic men. Arch Dis Child 1993; 68(1): 133-134.
46. Goldman E, Miller R, Lee CA. A family with HIV and haemophilia. AIDS Care 1993; 5(1): 79-85.
47. Dublin S, Rosenberg PS, Goedert JJ. Patterns and predictors of high-risk sexual behavior in female partners of HIV-infected men with hemophilia. AIDS 1992; 6(5): 475-482.
48. Anonymous. HIV-1 infection and artificial insemination with processed semen. MMWR Morb Mortal Wkly Rep 1990; 39(15): 249-256.
49. Semprini AE. Insemination of HIV-negative women with processed semen of HIV-positive partners [letter; comment]. Lancet 1993; 341(8856): 1343-1344.
50. Rabkin CS, Hilgartner MW, Hedberg KW et al. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992; 267(8): 1090-1094.
51. Simpson GR, Schulz TF, Whitby D et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen [see comments]. Lancet 1996; 348(9035): 1133-1138.
52. Neri A, Barriga F, Inghirami G et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma [see comments]. Blood 1991; 77(5): 1092-1095.
53. Leyva WH, Knutsen AP, Joist JH, Disappearance of a high response factor VIII inhibitor in a hemophiliac with AIDS. Am J Clin Pathol 1988; 89(3): 414-418.
54. Ragni MV, Ruben FL, Winkelstein A, Spero JA, Bontempo FA, Lewis JH. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med 1987; 109(5): 545-549.
55. Bray GL, Kroner BI, Arkin S et al. Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study. Am J Hematol 1993; 42(4): 375-379.
56. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309(8): 453-458.
57. Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies. Blood 1989; 73(7): 1859-1863.
58. Goldsmith JM, Deutsche J, Tang M, Green D. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates. Thromb Haemost 1991; 66(4): 415-419.
59. de Biasi R, Rocino A, Miraglia E, Mastrullo L, Quirino AA. The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate [see comments]. Blood 1991; 78(8): 1919-1922.
60. Seremetis SV, Aledort LM, Bergman GE et al. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status [see comments]. Lancet 1993; 342(8873): 700-703.
61. Sabin C, Pasi J, Phillips A et al. CD4 + counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic paients. Thromb Haemost 1994; 72: 214-217.